XML 70 R53.htm IDEA: XBRL DOCUMENT v3.23.1

Revenue - Seagen Agreement (Details) - Seagen - License Agreement [Member] $ in Millions	1 Months Ended
	Oct. 31, 2022 USD ($)	Sep. 30, 2022 USD ($) item
Disclosure of disaggregation of revenue from contracts with customers [line items]
Non-refundable upfront payment received	$ 50.0
Maximum amount of nonrefundable upfront payment receivable		$ 650.0
Additional tumor targets | item		2
Buy-up fee		$ 35.0
Decrease in certain future milestones		30.00%
Years of sale for royalties payable		10 years
Maximum amount of reimbursement entitled to receive		$ 6.5

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of buy-up fee.

+ References

No definition available.

+ Details

Name:	lvtx_BuyUpFeeAmount
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of maximum non-refundable upfront payment receivable.

+ References

No definition available.

+ Details

Name:	lvtx_MaximumNonRefundableUpfrontPaymentReceivable
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Maximum additional tumor targets number.

+ References

No definition available.

+ Details

Name:	lvtx_MaximumNumberOfAdditionalTumorTargets
Namespace Prefix:	lvtx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of maximum reimbursement entitles to received.

+ References

No definition available.

+ Details

Name:	lvtx_MaximumReimbursementEntitledToReceive
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Percentage of increase (decrease) in certain future milestones in the event we exercise the buy-up option and pay the buy-up fee.

+ References

No definition available.

+ Details

Name:	lvtx_PercentageOfIncreaseDecreaseInCertainFutureMilestones
Namespace Prefix:	lvtx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Non-refundable upfront payment received under research and license agreement.

+ References

No definition available.

+ Details

Name:	lvtx_ResearchAndLicenseAgreementNonRefundableUpfrontPaymentReceived
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Years of sale for royalties payable under research and license agreement.

+ References

No definition available.

+ Details

Name:	lvtx_ResearchAndLicenseAgreementRoyaltiesPayableYearsOfSale
Namespace Prefix:	lvtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_CounterpartiesAxis=lvtx_SeagenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	lvtx_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=lvtx_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: